RxDoctor Payments Data

Gabriel Carrillo, DO

Family Medicine · Belfry, KYNPI 1376032904

Payments from drug & device makers

$352in general payments, 2019–2025

Across 20 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$121
  • Lilly USA, LLC$58
  • AbbVie$54
  • Gilead$53
  • Boehringer Ingelheim$33
  • Averitas Pharma Inc.$17
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$352100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$352 in reported general payments places this provider in the 35th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$20,853
Medicare patients
47
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide25$34,016
FarxigaDapagliflozin Propanediol39$28,008
EliquisApixaban34$19,410
MounjaroTirzepatide13$17,510
JardianceEmpagliflozin13$15,745
XareltoRivaroxaban25$13,332
EntrestoSacubitril/Valsartan17$10,727
LinzessLinaclotide12$6,231
Atrovent HfaIpratropium Bromide11$4,793
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen72$1,518
Albuterol Sulfate HfaAlbuterol Sulfate46$1,068
Metoprolol Succinate112$1,044
Gabapentin112$1,001
Pantoprazole Sodium128$980
Theophylline ErTheophylline Anhydrous22$974

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$58$51,52638 claims
Boehringer IngelheimJardiance$33$15,74513 claims
AbbVieLinzess, Synthroid$54$6,99027 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Belfry

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →